Document is current
Any future updates will be listed below
-
Authors
Miyoshi, Jun https://orcid.org/0000-0002-6883-1930
Hisamatsu, Tadakazu
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 12 December 2024
First Online: 22 December 2024
Declarations
:
: Jun Miyoshi has received grant support from AbbVie GK; and received consulting and lecture fees from EA Pharma Co., Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Jansen Asia Pacific Pte. Ltd., Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, JIMRO Co., Miyarisan Co., Ltd., and Takeda Pharmaceutical Co., Ltd. Tadakazu Hisamatsu has performed Joint Research with Alfresa Pharma Co., Ltd., and EA Pharma Co., Ltd.; received grant support from AbbVie GK, Boston Scientific Corp., EA Pharma Co., Ltd., JIMRO Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Inc., and Takeda Pharmaceutical Co., Ltd., and received consulting and lecture fees from AbbVie GK, EA Pharma Co., Ltd., Janssen Research & Development, LLC., Gilead Sciences Inc., Eli Lilly and Co., Bristol Myers Squibb, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., and Kissei Pharmaceutical Co., Ltd.
